Total Payments
$45,969
2023 Payments
$157.51
Companies
13
Transactions
85
Medicare Patients
691
Medicare Billing
$113,425
Payment Breakdown by Category
Consulting$37,180 (80.9%)
Food & Beverage$3,304 (7.2%)
Travel$3,167 (6.9%)
Other$2,310 (5.0%)
Education$7.93 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $37,180 | 10 | 80.9% |
| Food and Beverage | $3,304 | 58 | 7.2% |
| Travel and Lodging | $3,167 | 15 | 6.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,310 | 1 | 5.0% |
| Education | $7.93 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $45,325 | 65 | $0 (2022) |
| Abbott Laboratories | $157.51 | 3 | $0 (2023) |
| Dova Pharmaceuticals | $130.74 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $70.81 | 4 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $66.39 | 3 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $45.56 | 2 | $0 (2017) |
| Medtronic USA, Inc. | $45.20 | 1 | $0 (2020) |
| Alnylam Pharmaceuticals Inc. | $29.88 | 1 | $0 (2022) |
| AbbVie, Inc. | $24.85 | 1 | $0 (2019) |
| Intercept Pharmaceuticals, Inc. | $23.09 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $157.51 | 3 | Abbott Laboratories ($157.51) |
| 2022 | $447.76 | 6 | Gilead Sciences, Inc. ($402.92) |
| 2021 | $4,779 | 5 | Gilead Sciences, Inc. ($4,749) |
| 2020 | $3,950 | 8 | Gilead Sciences, Inc. ($3,905) |
| 2019 | $7,193 | 13 | Gilead Sciences, Inc. ($7,038) |
| 2018 | $6,641 | 6 | Gilead Sciences, Inc. ($6,582) |
| 2017 | $22,801 | 44 | Gilead Sciences Inc ($22,648) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/04/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $55.05 | General |
| Category: Neuromodulation | ||||||
| 04/04/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: Neuromodulation | ||||||
| 03/23/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $71.07 | General |
| Category: Neuromodulation | ||||||
| 11/06/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $122.79 | General |
| 11/06/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $39.60 | General |
| 11/05/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $120.53 | General |
| 08/17/2022 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: Genetic Disease | ||||||
| 03/24/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $120.00 | General |
| 02/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Gastroenterology | ||||||
| 11/16/2021 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Hepatitis B Vaccine | ||||||
| 07/28/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Gastroenterology | ||||||
| 05/26/2021 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,370.00 | General |
| 05/11/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $69.17 | General |
| 01/27/2021 | Gilead Sciences, Inc. | Vemlidy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: HBV | ||||||
| 09/23/2020 | Gilead Sciences, Inc. | Vemlidy (Drug) | Education | In-kind items and services | $7.93 | General |
| Category: HBV | ||||||
| 03/11/2020 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $71.92 | General |
| 03/11/2020 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $18.14 | General |
| 03/11/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.70 | General |
| 03/11/2020 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $9.54 | General |
| 03/03/2020 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,610.00 | General |
| 02/27/2020 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $172.00 | General |
| 01/22/2020 | Medtronic USA, Inc. | TARGETSTIM (Device) | Food and Beverage | In-kind items and services | $45.20 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/05/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.95 | General |
| 11/09/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $116.46 | General |
| 11/09/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $116.46 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 218 | 376 | $235,621 | $40,303 |
| 2022 | 6 | 128 | 232 | $116,868 | $20,136 |
| 2021 | 7 | 176 | 299 | $186,985 | $29,786 |
| 2020 | 8 | 169 | 291 | $139,560 | $23,200 |
Total Patients
691
Total Services
1,198
Medicare Billing
$113,425
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 75 | $73,425 | $12,022 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 92 | $63,388 | $10,355 | 16.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 123 | $39,606 | $8,578 | 21.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $30,261 | $4,352 | 14.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $11,495 | $2,061 | 17.9% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 18 | 18 | $10,566 | $1,696 | 16.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 16 | 16 | $6,880 | $1,238 | 18.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 98 | $33,329 | $6,526 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 52 | $30,675 | $4,981 | 16.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 30 | $20,175 | $2,851 | 14.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 20 | $12,575 | $2,550 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $13,263 | $2,273 | 17.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 17 | $6,851 | $954.58 | 13.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 41 | 125 | $86,785 | $11,773 | 13.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 51 | $26,928 | $5,212 | 19.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 30 | $22,350 | $4,280 | 19.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 43 | $15,869 | $3,008 | 19.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $16,319 | $2,450 | 15.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 16 | $11,200 | $2,006 | 17.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 16 | $7,534 | $1,058 | 14.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 35 | 74 | $40,700 | $5,730 | 14.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 26 | 52 | $27,560 | $4,966 | 18.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 26 | 66 | $24,090 | $4,294 | 17.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 14 | $14,490 | $2,590 | 17.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 34 | $12,750 | $2,120 | 16.6% |
About Dr. Harmit Kalia, D.O
Dr. Harmit Kalia, D.O is a Internal Medicine healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1518136860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harmit Kalia, D.O has received a total of $45,969 in payments from pharmaceutical and medical device companies, with $157.51 received in 2023. These payments were reported across 85 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($37,180).
As a Medicare-enrolled provider, Kalia has provided services to 691 Medicare beneficiaries, totaling 1,198 services with total Medicare billing of $113,425. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Transplant Hepatology
- Location Manhasset, NY
- Active Since 02/20/2008
- Last Updated 08/10/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518136860
Products in Payments
- Vemlidy (Drug) $15,505
- Vosevi (Drug) $5,282
- Epclusa (Drug) $245.53
- PROCLAIM (Device) $157.51
- Doptelet (Drug) $130.74
- XIFAXAN (Drug) $111.95
- ZEPATIER (Drug) $70.81
- TARGETSTIM (Device) $45.20
- GIVLAARI (Drug) $29.88
- Mavyret (Drug) $24.85
- OCA (Drug) $23.09
- Nexavar (Drug) $21.60
- Heplisav-B (Drug) $14.99
- Prolia (Biological) $13.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Manhasset
Anna Imperato, M.d, M.D
Internal Medicine — Payments: $593,858
Internal Medicine $593,858
Bradley Sherman, Md, MD
Internal Medicine — Payments: $31,930
Internal Medicine $31,930
Dr. Samy Selim, Md, MD
Internal Medicine — Payments: $24,755
Internal Medicine $24,755
Emad Sedki, M.d, M.D
Internal Medicine — Payments: $14,573
Internal Medicine $14,573
Suchet Kumar, M.d, M.D
Internal Medicine — Payments: $9,358
Internal Medicine $9,358
Mr. Paul Schwartz, M.d, M.D
Internal Medicine — Payments: $7,084
Internal Medicine $7,084